Related by context. All words. (Click for frequent words.) 80 Thiarabine 74 generation nucleoside analog 73 HuMax CD#b 72 ATRA IV 72 LymphoStat B belimumab 72 HuMax Wnt 72 Meets Primary Endpoint 72 Crofelemer budesonide foam 71 metaglidasen 71 novel VDA molecule 71 CYT# potent vascular disrupting 71 dimebon latrepirdine 71 Completes Patient Enrollment 70 XL# anticancer compounds 70 BCG refractory carcinoma 70 HuMax TAC 70 AAG geldanamycin analog 70 Zicam Cold Remedy RapidMelts 70 modified glutathione analog 70 Symbioscience WISDOM PANEL 70 LymphoStat B TM 70 Glufosfamide 70 clinical trials Archexin 70 oral picoplatin 70 Bayer HealthCare Onyx Pharmaceuticals 69 Combination REOLYSIN R 69 Etelos Cloud 69 TNF alpha selectively neutralizing 69 Hsp# Inhibitor 69 refractory chronic lymphocytic 69 rusalatide acetate 69 oncolytic virus therapies 69 IMPDH inhibitor 69 product platforms AZX# 69 HuMax 69 Initiates Enrollment 69 liposomal formulation 69 GVAX ® 69 PI3K/Akt pathway inhibitor 69 oral chemotherapeutic agent 69 agonistic human 69 erlotinib Tarceva R 69 HuCAL PLATINUM ® CysDisplay 69 Tezampanel 69 Xeloda ® 69 com BlackSingles.com R 69 vinorelbine tartrate 69 Storage Made Simple 68 developing Bicifadine serotonin 68 tumor activated prodrug 68 PNP inhibitor 68 candidates Azedra TM 68 CCR9 antagonist 68 personalized cellular immunotherapy 68 pralatrexate injection folate analogue 68 Panzem R 68 pathophysiological effects 68 evaluating tivozanib 68 orally administered inhibitor 68 RANK Ligand inhibitor 68 Initiates Phase II 68 Network Uptime Money 68 brand ciclesonide HFA 68 CCX# B 68 ® bortezomib 68 product Fentanyl TAIFUN 68 TKB# 68 Xanafide 68 accumulate preferentially 68 TM Aganocide 68 Initiated Phase 68 platinum chemotherapeutic 68 CYP#A# CYP#D# 68 HuMax EGFr 68 Archexin 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 methylnaltrexone bromide 68 Pruvel TM 67 leading oral taxane 67 Alfacell proprietary ribonuclease 67 Veronate R 67 demonstrated antitumor activity 67 Antitumor Activity 67 VEGFR2 inhibitor 67 Solazed TM 67 formerly LymphoStat B 67 acyclovir Lauriad R 67 topical gel formulation 67 oral proteasome inhibitor 67 Telik logo TELINTRA 67 YONDELIS 67 HGS ETR1 mapatumumab 67 HuMax TF 67 Omacetaxine 67 Empatic ™ 67 TRANSDUR ™ 67 lexidronam injection 67 Delafloxacin 67 Albuferon TM 67 Elotuzumab 67 Cardium Therapeutics TM 67 DexaSite 67 Initiate Phase 67 delivers fluocinolone acetonide FA 67 signal detection CTSD 67 protein tyrosine phosphatase 1B 67 indolent follicular non 67 Back Guar 67 Vaccine Adjuvant 67 Initiate Clinical Trial 67 humanized therapeutic 67 somatostatin analog 67 Serostim ® 67 platform HDL Mimetic 67 sorafenib tablets 67 HuMax HepC 67 ALN TTR 67 metastatic castration resistant 67 oral nucleoside analogue 67 robust interlibrary loan 67 MSCRAMM ® 67 sunitinib Sutent ® 67 Oral NKTR 67 Initiates Clinical Trials 67 JAK2 Inhibitor 67 TO AVOID PREGNANCY WHILE 67 Alocrest 67 DNA methyltransferase inhibitors 67 dasatinib Sprycel 67 NUVIGIL ® 67 NASH Huntington 67 Racivir 67 sapacitabine CYC# 67 Zorbtive TM 67 Mitral Contour System 67 CTAP# Capsules 67 Personalized Immunotherapy 67 ® EBLY ® MASTERFOODS 66 NS5B polymerase 66 PEGylated Fab fragment 66 targeted radiotherapeutic 66 ALN PCS 66 CIMZIA ™ 66 oral prodrug 66 ALN TTR# 66 world safest multivalent 66 Preclinical Study 66 Dose Escalation 66 IMiDs ® 66 TURNING INSIGHTS INTO HOPE 66 Phase IIb Trial 66 Transdermal Patch 66 carcinoma mCRC 66 Budesonide foam crofelemer 66 technology underlying Medidur 66 non porcine pancreatic 66 Novel Oral 66 dependent kinase inhibitor 66 Aflibercept 66 Perifosine KRX 66 SPL# Gel vaginal microbicide 66 bucindolol hydrochloride 66 humanized interleukin 6 66 USHE groundbreaking pocket BLU 66 TELINTRA R 66 MKC# MKC# PP 66 Epothilone D 66 CCX# 66 product candidate Lpathomab 66 gastrin analogue TT 66 trastuzumab Herceptin R 66 apomorphine hydrochloride 66 consortial borrowing solution 66 dasatinib Sprycel ® 66 Vicinium TM 66 Adjuvant Treatment 66 Dapagliflozin 66 SPRYCEL ® 66 inflammatory PDE 66 virus HCV protease inhibitor 66 PATHFINDER ® TRACER 66 vaccine RiVax TM 66 Safinamide 66 R rilonacept Injection 66 TRANSDUR ® 66 Bucindolol 66 Belimumab 66 By JENNIFER LEARN 66 SinuNase ™ 66 FOLFOX6 chemotherapy regimen 66 deCODE ProstateCancer TM 66 alpha folate receptor 66 plus prednisone prednisolone 66 next generation URAT1 66 kidney urologic 66 oral dihydropyrimidine dehydrogenase DPD 66 novel histone deacetylase 66 orally inhaled migraine 66 metastatic hormone refractory 66 R sorafenib tablets 66 Presents Preclinical Data 66 Annamycin 66 Hormone Refractory Prostate Cancer 66 LEVADEX TM 66 Nventa proprietary CoVal 66 Custirsen 66 successfully commercialize Iluvien 66 PRN FDA Approves 66 DG# compounds targeting 66 Product candidate Serada 66 investigational immunotherapy 66 PEGylated anti 66 Imprime PGG ® 66 evaluating mipomersen 66 R MSCRAMM 66 Sangamo BioSciences Announces 66 non nucleoside inhibitor 66 Bosutinib 66 Study Evaluating 66 Mg Usa 66 oral ghrelin agonist 66 lintuzumab SGN 66 topically applied SEPA 66 Ophena 66 Dural Regeneration Matrix 66 pan histone deacetylase 66 relapsed MM 66 Aganocide ® 66 Lipid Polymer Micelle LPM 66 Nexavar sorafenib tablets 66 5 FU leucovorin 66 XmAb ™ 65 legendary SPACE INVADERS 65 evaluating picoplatin 65 Phase 2b Clinical Trial 65 Its THOR LVX 65 paclitaxel Taxol ® 65 TBC# 65 Prolongs Survival 65 folate analogue metabolic 65 Mg Uk 65 METOZOLV ™ ODT metoclopramide 65 DXL ™ 65 Wafer polifeprosan 65 approved incretin mimetic 65 THR beta agonist 65 introduced NEUGENE 65 Pirfenidone 65 evaluating satraplatin 65 Trial Evaluating 65 CD# CEA 65 R BorderGuard 65 FUSILEV ® 65 Phase 1b clinical trials 65 radiation sensitizer 65 ® SHOWTIME FAMILYZONE 65 telomerase therapeutic 65 Ceflatonin R 65 ABLYNX 65 ZFP Therapeutics 65 CTA# Injection 65 recombinant adeno associated 65 recurrent metastatic ovarian cancer 65 SATURA ® 65 Demonstrates Positive 65 antiangiogenesis therapies 65 Files IND 65 pentadentate logo R 65 anti amnesic 65 hyaluronidase enzyme 65 proteasome inhibitor 65 drug pipeline TAFA# 65 TRIOLEX HE# 65 Janus kinase 65 cathepsin K inhibitor 65 rxRNA 65 Tarceva TM 65 CysDisplay R 65 Interferon alpha 65 essential thrombocythemia ET 65 OMNARIS HFA 65 HCl PEPCID ® famotidine 65 small molecule thrombopoietin 65 metastatic castrate resistant 65 Myocet 65 PORxin TM platforms 65 treat male hypogonadism 65 FDA APPROVES 65 Rigel R# 65 Pivotal Phase III 65 POGO ™ 65 monoclonal antibody IgG1 Mab 65 TNF Tumor Necrosis Factor 65 Phase 2a Trial 65 Tengion Neo Bladder Augment 65 mertansine 65 OncoVEX GM CSF 65 KNS # 65 vapreotide acetate 65 Receives Orphan Drug Designation 65 aldehyde dehydrogenase ALDH2 deficiency 65 reslizumab 65 Epratuzumab 65 non metastatic resectable 65 Randomized Phase 65 Achieves Primary Endpoint 65 PDE4 modulators 65 acetonide FA 65 novel oral tubulin 65 Aplidin R 65 Salix Pharmaceuticals Announces 65 R#/MEM # 65 arthritis PsA 65 catheter occlusion 65 candidates Azedra 65 CG# oncolytic virus 65 hypoxia selective 65 seliciclib CYC# 65 lenalidomide Revlimid R 65 IMA# 65 sarcoma melanoma 65 Bezielle 65 Aeolus Pharmaceuticals Announces 65 Oral Fingolimod 65 novel orally inhaled 65 Advanced Renal Cell 65 PSMA ADC 65 Angiocept 65 forodesine purine nucleoside phosphorylase 65 peptidic compound 65 R Saizen R 65 Panzem R NCD 65 Virulizin ® 65 hereditary emphysema 65 Letairis ambrisentan 65 Pivotal Phase 65 lead molecular radiotherapeutic 65 Phase Ib IIa 65 Paraplatin ® 65 PROVENGE ® 65 Chrysalin r rusalatide acetate 65 NOTE POSIDUR ™ 65 Dual Opioid 65 Degarelix 65 tenofovir disoproxil fumarate Viread 65 Chronic Hepatitis C 65 TRIOLEX HE# APOPTONE HE# 65 MKC# 65 Library HuCAL 65 pan HDAC inhibitor 65 Bavituximab 65 MKC# MT 65 HCV NS5B polymerase 65 Amgen Neulasta R 65 * olmesartan medoxomil 65 Initiates Dosing 65 mGluR2 positive 65 PDE4 inhibitor 65 pipeline ImmunoGen collaborators 65 nilotinib Tasigna ® 65 unique alkylating agent 65 immunotherapeutic agent 65 BRIM2 65 GVAX R 65 Zolpimist ™ 65 Granted Orphan Drug 65 erlotinib Tarceva ® 65 5 HT3 antagonist 65 selective orally bioavailable 65 Antigenics QS 64 Vidofludimus 64 CDK cyclin dependent 64 generation DACH Platinum 64 Capesaris 64 Intravenous Human 64 AzaSite ISV 64 polymerase inhibitor 64 Microwave Ablation System 64 Pertuzumab 64 valtorcitabine 64 allosteric modulator NAM 64 renin inhibition promising 64 Elagolix 64 Drug Candidate 64 Disease IBD 64 Phase 2a Clinical Trial 64 OncoVex 64 'S ® DOLMIO 64 Nexavar ® 64 Ovitrelle R Serostim 64 Liposomal 64 INSPIRE Trial Phase III 64 ® ZEVALIN 64 Paybefore Magazine 64 Cloretazine ® 64 Phase 1b Clinical Trial 64 ocular formulation 64 Vidaza R 64 selective modulator 64 Peginterferon alfa 2b 64 FUSILEV enhances 64 HQK 64 iobenguane 64 transthyretin TTR 64 Vitrasert R 64 Xcellerated T Cells 64 Locked Nucleic Acid 64 UltiMAb TM 64 CRLX# 64 AEG# 64 recombinant PSMA vaccine 64 6 sulfatase 64 SinuNase TM 64 induced mucositis 64 MAGE A3 ASCI 64 Phase #b/#a clinical 64 Ribavirin causes 64 Presents Preclinical 64 patented Visto Mobile 64 Vidaza ® 64 Vicriviroc 64 Patients Treated With 64 Anti Tumor 64 somatostatin analogue 64 certain protein tyrosine 64 Exelixis compounds 64 Pegasys ® 64 Sapacitabine 64 selective kinase inhibitor 64 Biopharmaceuticals AG 64 Tengion Neo Urinary Conduit 64 cMET 64 include Alferon N 64 vaccines oncolytic virus 64 topical antifungal product 64 alvespimycin 64 sodium glucose cotransporter 64 PEGylated interferon 64 Staphylococcus aureus Immune Globulin 64 ospemifene 64 Daclizumab 64 lightly carbonated grape 64 Additionally Soligenix 64 InterconnectNow ™ technology 64 Commences Phase 64 include VALSTAR TM 64 Small Modular SMIP 64 AVI antiviral programs 64 Therapeutic Competitors Companies 64 PrevOnco ™ 64 novel synthetic peptide 64 include PLX IBD 64 Completes Enrollment 64 molecular imaging radiopharmaceutical 64 Darinaparsin 64 mTOR mammalian target 64 selective A2A adenosine receptor 64 Provectus Pharmaceuticals specializes 64 TMC xtra 64 DURECT proprietary 64 First Patient Dosed 64 MT# MEDI 64 oral dual endothelin 64 ADVANCE ILLUMINATE 64 Terremark acclaimed Infinistructure 64 Curaxin CBLC# 64 angiotensin analog 64 Nilotinib 64 Temsirolimus 64 Zalypsis 64 Initiates Clinical 64 Intravenous CP 64 Loceryl ® 64 VANTAS ® 64 anti EGFR antibody 64 Prodarsan R 64 clobetasol propionate Foam 64 Initiate Phase III 64 Submits NDA 64 nasal calcitonin product 64 Bafetinib 64 resistant hormone refractory 64 ACTEMRA TM 64 Quinamed 64 Atripla combines 64 candidate XP# 64 Liprotamase 64 cisplatin gemcitabine 64 Gastrointestinal Stromal Tumors 64 sunitinib malate 64 solid tumors ZYBRESTAT 64 Voreloxin 64 Gastrointestinal Liner 64 include Healive 64 Gemzar ® 64 initiated Phase Ib 64 specific CCR9 antagonist 64 DCVax R 64 Besivance 64 fosbretabulin 64 Tumour Vascular Disrupting Agent 64 Anavex #-# 64 docetaxel Taxotere ® 64 triggers apoptosis programmed 64 Alseres Cethrin 64 Serdaxin ® 64 ChronVac C R 64 individualized cellular immunotherapy 64 Biliary System 64 lead Aganocide compound 64 Stimulon adjuvant 64 multi kinase inhibitor 64 FOLOTYN ® 64 investigational oral inhibitor 64 CINQUIL 64 Cardio Vascu Grow 64 MET amplification 64 VisionDirect.com ™ 64 receptor tyrosine kinase inhibitor 64 vidofludimus 64 targeted antifolate 64 alfa 2a 64 Onconase 64 Fludara ® 64 forodesine 64 D aspartate NMDA receptor 64 novel oral anticoagulant 64 armodafinil Tablets C 64 volociximab 64 Eyvind Brynildsen Mitsubishi Lancer 64 reduce serum phosphate 64 paclitaxel poliglumex 64 sapropterin dihydrochloride Tablets 64 PMX # heptagonist 64 novel topoisomerase 64 Copegus R 64 ENMD # 64 Spiegelmer ® 64 Camptosar ® 64 Tesetaxel 64 ALVESCO R 64 Septin9 biomarker 64 metastatic colorectal 64 Nexavar sorafenib 64 ALVESCO ® 64 counter brand ESOTERICA 64 Treatment Naïve 64 investigational pharmacologically unique 64 Severe Sepsis 64 Zoraxel TM 64 BHT DNA 64 registrational Phase 64 Aloprim TM allopurinol sodium 63 Dasatinib 63 ACTIQ ® 63 Patient Enrollment 63 proprietary PharmacoSurgery ™ 63 RNAi Therapeutic 63 AN# topical anti 63 IMiDs 63 mark eOn 63 systemic juvenile idiopathic 63 hematological tumors 63 systemic anaplastic large 63 Clevudine 63 CRM# Protein 63 omacetaxine mepesuccinate 63 CYP#A# isoenzyme 63 HYVISC ® treatment 63 Ophena TM 63 R roscovitine 63 NMT Medical Announces 63 Phase 1a clinical 63 albiglutide 63 First Patient Enrolled 63 Frozen Shoulder syndrome Adhesive 63 Begins Dosing 63 Aplidin 63 Locteron ® 63 RhuDex ® 63 Amigal TM 63 radezolid 63 NPC 1C 63 imatinib Gleevec ® 63 Syncria R 63 Campath alemtuzumab 63 FOR NINTENDO DS 63 radiation chemoradiation 63 bevacizumab Avastin R 63 MYDICAR ® 63 HCV RNA polymerase 63 interferon gamma 1b 63 novel emulsion formulation 63 oral ridaforolimus 63 active AKT inhibitor 63 Initiates Phase III 63 Ozarelix 63 ThermoDox R 63 Demonstrates Sustained 63 Pruvel ™ 63 P#X# antagonist 63 Recombinant Human 63 memantine HCl 63 AFREZZA TM 63 human IgG1 monoclonal 63 Quinamed R 63 Aurora Kinase 63 Talabostat 63 receptor inhibiting monoclonal 63 interferon alpha IFN 63 2 methoxyestradiol 63 SABER ™ 63 Biomerix Corporation 63 including eniluracil ADH 63 S1P antibody 63 Second Pivotal Phase 63 PRT# 63 5 HT2A serotonin 63 TRACON Pharmaceuticals 63 Panzem NCD 63 PATENT FOR 63 thetreatment 63 Underground Indianapolis Speedrome 63 targeting Inflammatory Bowel 63 elderly myelodysplastic syndromes 63 induced tumor regression 63 IRX 2 63 * Azixa 63 Ep CAM 63 pharmacogenomic translational research 63 azilsartan medoxomil 63 Phase III Clinical Trial 63 evaluating T DM1 63 Medoxomil 63 PC Cards Expedite 63 estrogen receptor antagonist 63 Solazed ™ 63 huC# DM4 63 ™ EnerLogic ™ FormulaOne 63 novel antimitotic agent 63 Receives Orphan Drug 63 AVCHD Playback 63 DAVANAT 63 RE MODEL 63 RhuDex R 63 Synta Announces 63 TLR7 agonist 63 CIMZIA TM 63 Zicam Cold Remedy Chewables 63 ceftazidime 63 PHASE III 63 Clinical Trial Results 63 Using Dip Pen 63 include ColorectAlert TM 63 Demonstrates Significant 63 Clolar ® 63 nucleoside analog 63 Complicated Skin 63 vascular disrupting agent 63 HCV Protease Inhibitor 63 mTOR inhibitor 63 undergoing elective percutaneous 63 Romiplostim 63 vaccine ChronVac C 63 Empatic TM 63 Savella ® 63 AzaSite TM 63 Medarex logo 63 Phase III Pivotal 63 novel synthetic PEGylated 63 catheter occlusion CO 63 oral rivaroxaban 63 HER2 ErbB2 63 RapMAT ® 63 occlusion PAO 63 attach auristatin 63 gastrointestinal stromal 63 protein kinase inhibitor 63 GW# [003] 63 trastuzumab DM1 T DM1 63 motexafin gadolinium Injection 63 Bavarian Nordic patented 63 EndoTAG TM 63 RAS MAPK pathway 63 selective androgen receptor modulator 63 signature Bottomless Beverages 63 G GLASS 63 oral isoform selective HDAC 63 ® REFLEXX ® MICROVISTA 63 VentiRx Pharmaceuticals 63 Receives Approvable Letter 63 THE REBELS 63 Unigene nasal calcitonin 63 Company TAIFUN R 63 novel therapeutic antibodies 63 proprietary BiTE ® 63 ALN HPN 63 MVA BN R 63 toenail onychomycosis 63 targeting CD# 63 interferon beta 1a infertility 63 Protease Inhibitor 63 Namenda Memantine HCl 63 Onyx Pharmaceuticals Announces 63 cetuximab Erbitux R 63 cetuximab Erbitux ® 63 Ixempra 63 Copegus ® 63 Kinase Inhibitor 63 Acetavance TM intravenous acetaminophen 63 Oracea TM 63 ARRY # 63 MEK Inhibitor 63 CCR5 mAb 63 Vivecon 63 MTP inhibitor 63 Traficet EN 63 CB2 selective receptor agonist 63 ® lenalidomide 63 TRAIL receptor antibodies 63 Vaxfectin 63 ® Untold Legends 63 HGS# 63 EGS# 63 targeted alpha folate 63 progressive metastatic prostate 63 Present Preclinical Data 63 Dabigatran etexilate 63 Immunomedics Announces 63 thrombin component 63 R memantine HCl 63 palonosetron hydrochloride Injection Dacogen 63 Kuvan R 63 ELADUR TM 63 ™ ZAGG LEATHERskins 63 Phase IIb Clinical Trial 63 ADP receptor antagonist 63 Relapsed Refractory 63 Potelligent TM 63 DIFICID ™ 63 tramiprosate Alzhemed TM 63 R bortezomib 63 Modrenal R 63 Fc fusion protein 63 Levoleucovorin 63 DUROS 63 ® PLEDGE 63 ELND-#/AZD-# 63 sorafenib Nexavar ® 63 NeoLipid R 63 rALLy clinical trial 63 pain palliation 63 Cannabinor 63 NDA Submission 63 systemic RNAi therapeutic 63 LAB CGRP 63 Telik Announces 63 Pooled Analysis 63 clinical trials Archexin ® 63 HuCAL GOLD R 63 Vitaxin 63 Solzira ™ 63 JAK1 63 Phase 2b Trial 63 Polymerase Inhibitor 63 Epeius Biotechnologies Corporation 63 taxane derivative 63 rasagiline tablets 63 diarrhea predominant irritable 63 R Bortezomib 63 IAP inhibitor 63 Randomized Double blind 63 Janus Kinase 63 syndrome overactive bladder 63 var arrMeta = 63 HGS ETR2 63 Is Well Tolerated 63 Janis Joplin soundalike respiratory 63 compound INCB# 63 rheumatoid arthritis RA psoriatic 63 MuGard TM 63 APC Targeting Technology 63 var arrContent = 63 Taro Receives 63 COPEGUS R 63 bortezomib Velcade R 63 J Antimicrob Chemother 63 include Healive TM 63 Vitamin D analogue 63 Topline Results 63 miconazole Lauriad ® 63 Intravitreal injections 63 mGluR5 negative 63 Previously Untreated 63 Peginterferon Alfa 2a 63 Generx ® 63 treatment naïve genotype 63 delivery polymer matrix 63 Silodosin 63 BUPHENYL R sodium phenylbutyrate 63 BiTE R 63 Antithrombin 63 docetaxel Taxotere R 63 PF # [002] 63 Testosterone MDTS R 62 Seliciclib 62 delta opioid receptor 62 Phase #/#a trial 62 EDEMA3 62 Successfully Completes Phase 62 ViroPharma commercializes Cinryze 62 candidate deforolimus 62 OncoGel 62 either acutely decompensated 62 Initiates Phase 62 Mixing System RenalPure 62 davunetide intranasal AL 62 MEK inhibitor 62 Meetings Made Easy 62 infectious diseases autoimmune diseases 62 tumor xenograft models 62 protected Clearant Process 62 ® SHOWTIME WOMEN 62 Mipomersen 62 Irinotecan 62 B Anflu R 62 Tarvacin Anti Cancer 62 PROCTOCORT ® Suppository Hydrocortisone 62 small molecule Hedgehog 62 YOUR LOCAL ANIMAL SHELTER 62 APEX PD 62 Plus STAARVISC TM 62 4 PDE4 enzyme 62 castrate resistant prostate cancer 62 pioglitazone HCl 62 Demonstrates Potential 62 Luteinizing Hormone Releasing Hormone 62 INCB# [001] 62 PHX# 62 metastatic androgen independent 62 DRY REX TM THERMALONOx 62 PROCTOCORT R Suppository Hydrocortisone 62 Gene Expression RAGE 62 ABL inhibitor 62 Xcytrin R 62 adecatumumab MT# 62 overactive bladder VANTAS R 62 Vaxfectin ® 62 markets Testim ® 62 5 fluorouracil leucovorin 62 trial evaluating PRX# 62 Onalta 62 Secured Lock 62 catalytic antioxidant compounds 62 AdVac ® 62 plus Copegus 62 Mylan Receives Approval 62 Lenocta TM sodium stibogluconate 62 PREMIERSHIP TOTTENHAM HOTSPUR v 62 humanized anti 62 anionic backbone 62 anti atherothrombotic 62 receiving chemoradiation therapy 62 leukemia AML 62 mitoxantrone plus 62 Bazedoxifene 62 metformin HCl 62 YONDELIS R 62 novel tubulin binding 62 cutaneous T 62 Naproxcinod 62 Initiates Clinical Trial 62 DEB# 62 MCSP respectively 62 targeted diseased tissues 62 Peginterferon 62 allosteric modulator PAM 62 sargramostim 62 mild vasodilator 62 Afatinib 62 Paris Alternext ALGFT 62 Albuferon albinterferon alfa 2b 62 SUPPRELIN R LA 62 EGFr humanized monoclonal antibody 62 Catena ® 62 R bisoprolol Euthyrox 62 Anti Tumor Activity 62 refractory cutaneous T 62 psoriasis rheumatoid arthritis 62 commercializing dermatological products 62 HuLuc# 62 AAG KOS 62 DIGITAL SIGNAGE 62 includes TOLAMBA TM 62 & BOVESPA ENGI 62 Shows Promising 62 ISENTRESS raltegravir 62 capecitabine Xeloda 62 ketoconazole USP Gel 62 Novatel Wireless Merlin 62 PEGylated 62 Evoltra ® 62 R lenalidomide 62 nucleotide analogue 62 Peyronie disease Frozen Shoulder 62 Amplimexon 62 ELADUR ™ 62 metastatic pancreatic 62 dSLIM 62 Genasense oblimersen sodium Injection 62 prednisone prednisolone plus 62 Sirolimus eluting Coronary Stent 62 XmAb# 62 dihydroergotamine mesylate DHE 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 DGAT1 inhibitors 62 Luveris R Ovidrel R 62 non resectable metastatic 62 data management Clintrial 62 CYPHER R Sirolimus Eluting 62 vinca alkaloid 62 ® natalizumab 62 IMiDs ® compound 62 FEMALES SHOULD BE ADVISED 62 nilotinib Tasigna 62 small molecule tyrosine 62 var arrUrl = 62 corticosteroid dexamethasone 62 using Crucell PER.C6 62 refractory metastatic 62 polysaccharide polymer 62 Phase 2b Study 62 intranasal vaccines derived 62 dextromethorphan quinidine 62 Guanilib 62 topical agent Xantryl 62 Deforolimus 62 BARACLUDE R 62 RhuDex TM 62 Eculizumab 62 JAK Inhibitor 62 Tetanus Toxoid Reduced Diphtheria 62 AzaSite Xtra 62 label Lipofen R 62 ODT metoclopramide HCl PEPCID 62 Oral Cladribine 62 Factor VIIa 62 Symadex 62 Opterone R 62 humanized monoclonal antibodies 62 novel DACH platinum 62 bazedoxifene conjugated estrogens 62 phase IIa clinical 62 Simulect 62 Golimumab 62 Orally administered 62 Telatinib 62 ulimorelin 62 Eze Breeze R 62 oropharyngeal candidiasis OPC 62 specific lectin receptors 62 oral FTY# 62 IMiDs R 62 therapy Tovaxin 62 selective inverse agonist 62 ChromoCure develops 62 induced macular edema 62 ® SOURCEFIRE SOLUTIONS NETWORK 62 Inhalation Solution 62 NEBIDO VANTAS SUPPRELIN LA 62 proprietary intranasal insulin 62 telomerase inhibitor drug 62 RHUCIN ® 62 TLR agonists 62 mGluR5 NAM 62 OHR/AVR# 62 R pramlintide acetate 62 NeutroPhase TM 62 Retisert ® 62 Excellarate TM 62 biocompatible shelf stable 62 Aurexis R 62 Altera Nebulizer System 62 transcriptase inhibitor NNRTI 62 Xencor XmAb 62 selective agonist 62 Trobalt 62 PDX pralatrexate 62 Elvitegravir 62 pertuzumab 62 Lenocta TM 62 sapropterin dihydrochloride 62 Presents Positive 62 acne pustular acne 62 raw material Hydrapol 62 urethral bulking agent 62 Atridox R Atrisorb 62 Shows Promise Against 62 Investigational Treatment